Bionano Genomics
BNGO
32 hedge funds and large institutions have $1.35M invested in Bionano Genomics in 2025 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 8 closing their positions.
225% more capital invested
Capital invested by funds: $417K → $1.35M (+$937K)
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
6.19% more ownership
Funds ownership: 2.51% → 8.7% (+6.2%)
0% more funds holding
Funds holding: 32 → 32 (0)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$585K |
| 2 |
DS
DRW Securities
Chicago,
Illinois
|
+$292K |
| 3 |
Two Sigma Investments
New York
|
+$70.1K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$69.1K |
| 5 |
Renaissance Technologies
New York
|
+$64K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$94.9K |
| 2 |
HF
HRT Financial
New York
|
-$34K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$26.6K |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$18K |
| 5 |
Morgan Stanley
New York
|
-$6.89K |
BNGO Hedge Fund Activity: Q4 2025 in Review
32 of the 8,238 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q4 2025, worth a combined $1.35M — up 225% from $417K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new BNGO positions and 8 closed out — a net gain of 1 holder — while 5 added to existing stakes and 8 trimmed.
The largest buyer was GSA Capital Partners, opening a new position worth an estimated $585K. The largest seller was UBS Group, cutting an estimated $94.9K.
- 32 institutional investors held Bionano Genomics (BNGO) as of Q4 2025, unchanged from Q3 2025.
- Funds reported $1.35M of Bionano Genomics stock for Q4 2025, up 225% quarter-over-quarter.
- 9 funds opened new Bionano Genomics positions in Q4 2025 and 8 closed out, a net change of +1 holder.
- The largest Bionano Genomics buyer in Q4 2025 was GSA Capital Partners, an estimated $585K added.
- The largest Bionano Genomics seller in Q4 2025 was UBS Group, an estimated $94.9K sold.
Based on aggregated 13F filings for Q4 2025.